Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pancreatic carcinoma surveillance in patients with familial melanoma.

Archives of dermatology - 1 Aug 2003

Parker Jana Foley, Florell Scott R, Alexander April, DiSario James A, Shami Paul J, Leachman Sancy A

Abstract excerpt

OBJECTIVE: To determine the optimal methods for pancreatic adenocarcinoma surveillance in high-risk patients with familial melanoma and cyclin-dependent kinase inhibitor 2A (CDKN2A) mutations. DESIGN: Case report with pedigree analysis and literature review, with an emphasis on guideline development for high-risk kindreds with familial pancreatic adenocarcinoma. SETTING: A university-affiliated familial melanoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Cyclin-Dependent Kinase Inhibitor p16

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Pancreatic Neoplasms

Share to Pedigree

Share to Population Surveillance

Share to Risk Factors

Share to Skin Neoplasms

Source

Identifiers

PMID: 12925390
DOI: 10.1001/archderm.139.8.1019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pancreatic carcinoma surveillance in patients with familial melanoma.PMID 12925390Read ↗

Clinical applications of melanoma genetics.Semantic proximity Read ↗

Familial melanoma, pancreatic cancer and germline CDKN2A mutationsSemantic proximity Read ↗

Familial melanoma.Semantic proximity Read ↗

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.Semantic proximity Read ↗

Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades.Semantic proximity Read ↗

Retrospective study of germline variants in patients with hereditary melanoma study criteria in a real clinical practice setting.Semantic proximity Read ↗

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.Semantic proximity Read ↗

CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations.Semantic proximity Read ↗

CDKN2A Gene Mutations: Implications for Hereditary Cancer SyndromesSemantic proximity Read ↗

Identification, genetic testing, and management of hereditary melanoma.Semantic proximity Read ↗

Exploring the Common Mutational Landscape in Cutaneous Melanoma and Pancreatic Cancer.Semantic proximity Read ↗

Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.